Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 8216578, 8 pages
https://doi.org/10.1155/2018/8216578
Research Article

Endogenous Secretory Receptor for Advanced Glycation End Products Protects Endothelial Cells from AGEs Induced Apoptosis

1Department of Endocrinology, Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, China
2Scientific Research Center, Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, China

Correspondence should be addressed to Xiahong Lin; moc.qq@2978633142

Received 21 December 2017; Accepted 5 March 2018; Published 10 April 2018

Academic Editor: Stephen H. Safe

Copyright © 2018 Guomin Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Yu and S. Park, “Cost of diabetes related chronic complication in South Korea 2011,” Value in Health, vol. 17, no. 7, p. A340, 2014. View at Publisher · View at Google Scholar
  2. S. Shantikumar, A. Caporali, and C. Emanueli, “Role of microRNAs in diabetes and its cardiovascular complications,” Cardiovascular Research, vol. 93, no. 4, pp. 583–593, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Basta, A. M. Schmidt, and R. de Caterina, “Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes,” Cardiovascular Research, vol. 63, no. 4, pp. 582–592, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Ott, K. Jacobs, E. Haucke, A. Navarrete Santos, T. Grune, and A. Simm, “Role of advanced glycation end products in cellular signaling,” Redox Biology, vol. 2, no. 1, pp. 411–429, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. H. Jang, E.-A. Kim, H.-J. Park et al., “Methylglyoxal-induced apoptosis is dependent on the suppression of c-FLIPL expression via down-regulation of p65 in endothelial cells,” Journal of Cellular and Molecular Medicine, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. A. A. Akhand, K. Hossain, H. Mitsui et al., “Glyoxal and methylglyoxal trigger distinct signals for MAP family kinases and caspase activation in human endothelial cells,” Free Radical Biology & Medicine, vol. 31, no. 1, pp. 20–30, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Li, Y. Liu, Y. Xiang, M. Lin, and J. Gao, “Ghrelin protects human umbilical vein endothelial cells against advanced glycation end products-induced apoptosis via NO/cGMP signaling,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 9, pp. 15269–15275, 2015. View at Google Scholar · View at Scopus
  8. L. Feng, M.-M. Zhu, W.-Q. Bu et al., “The C-terminal tails of 4,4'-diphenylmethane-bis(methyl) carbamate are essential for binding to receptor for advanced glycation end products to attenuate advanced glycation end products-induced inflammation and apoptosis responses in human umbilical vein endothelial cells,” Journal of Pharmacy and Pharmacology, vol. 68, no. 1, pp. 93–106, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Li, L. Zhang, C. Zhou, N. Lin, and A. Liu, “Sirt 1 activator inhibits the AGE-induced apoptosis and p53 acetylation in human vascular endothelial cells,” Journal of Toxicological Sciences, vol. 40, no. 5, pp. 615–624, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Chen, J. Jing, S. Yu et al., “Advanced glycation endproducts induce apoptosis of endothelial progenitor cells by activating receptor RAGE and NADPH oxidase/JNK signaling axis,” American Journal of Translational Research, vol. 8, no. 5, pp. 2169–2178, 2016. View at Google Scholar · View at Scopus
  11. B.-Y. Li, X.-L. Li, H.-Q. Gao et al., “Grape seed procyanidin B2 inhibits advanced glycation end product-induced endothelial cell apoptosis through regulating GSK3β phosphorylation,” Cell Biology International, vol. 35, no. 7, pp. 663–669, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Daffu, C. H. del Pozo, K. M. O'Shea, R. Ananthakrishnan, R. Ramasamy, and A. M. Schmidt, “Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond,” International Journal of Molecular Sciences, vol. 14, no. 10, pp. 19891–19910, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Cohen, “Perspectives on RAGE signaling and its role in cardiovascular disease,” American Journal of Medical Genetics Part A, vol. 161, no. 11, pp. 2750–2755, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Yonekura, Y. Yamamoto, S. Sakurai et al., “Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury,” Biochemical Journal, vol. 370, no. 3, pp. 1097–1109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Raucci, S. Cugusi, A. Antonelli et al., “A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10),” The FASEB Journal, vol. 22, no. 10, pp. 3716–3727, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. B. I. Hudson, A. M. Carter, E. Harja et al., “Identification, classification, and expression of RAGE gene splice variants,” The FASEB Journal, vol. 22, no. 5, pp. 1572–1580, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Koyama, T. Shoji, and H. Yokoyama, “Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 12, pp. 2587–2593, 2005. View at Publisher · View at Google Scholar
  18. A. M. Schmidt, M. Vianna, M. Gerlach et al., “Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface,” Journal of Biological Chemistry, vol. 267, no. 21, pp. 14987–14997, 1992. View at Google Scholar
  19. X. Lin, X. Chen, J. Ye et al., “Association between endogenous secretory receptor for advanced glycation-end products (esRAGE) and carotid intima-media thickness in type 2 diabetes,” Experimental and Clinical Endocrinology and Diabetes, vol. 122, no. 5, pp. 277–280, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Katakami, M. Matsuhisa, H. Kaneto et al., “Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes,” Atherosclerosis, vol. 204, no. 1, pp. 288–292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Piarulli, A. Lapolla, E. Ragazzi et al., “Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients,” Atherosclerosis, vol. 226, no. 1, pp. 252–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Di Pino, F. Urbano, R. M. Zagami et al., “Low endogenous secretory receptor for advanced glycation end-products levels are associated with inflammation and carotid atherosclerosis in prediabetes,” The Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 4, pp. 1701–1709, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. S. J. Yang, S. Kim, S. Y. Hwang et al., “Association between sRAGE, esRAGE levels and vascular inflammation: Analysis with 18F-fluorodeoxyglucose positron emission tomography,” Atherosclerosis, vol. 220, no. 2, pp. 402–406, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Heier, H. D. Margeirsdottir, M. Gaarder et al., “Soluble RAGE and atherosclerosis in youth with type 1 diabetes: A 5-year follow-up study,” Cardiovascular Diabetology, vol. 14, no. 1, article no. 126, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. H. M. Colhoun, D. J. Betteridge, P. Durrington et al., “Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial,” Diabetes, vol. 60, no. 9, pp. 2379–2385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Vazzana, M. T. Guagnano, C. Cuccurullo et al., “Endogenous secretory RAGE in obese women: Association with platelet activation and oxidative stress,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 9, pp. E1726–E1730, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. K. M. Choi, H. J. Yoo, H. Y. Kim et al., “Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness,” International Journal of Cardiology, vol. 132, no. 1, pp. 96–101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Moriya, M. Yamazaki, H. Murakami, K. Maruyama, and S. Uchiyama, “Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: The difference of soluble and endogenous secretory RAGE,” Journal of Stroke and Cerebrovascular Diseases, vol. 23, no. 10, pp. 2540–2546, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Fleige, V. Walf, S. Huch, C. Prgomet, J. Sehm, and M. W. Pfaffl, “Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR,” Biotechnology Letters, vol. 28, no. 19, pp. 1601–1613, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Zhang, Y. Li, Q. Huang et al., “MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer,” Cell Death & Differentiation, vol. 18, no. 11, pp. 1702–1710, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Li, J. Li, L. Cui et al., “Inhibitory effect of atorvastatin on AGE-induced HCAEC apoptosis by upregulating HSF-1 protein,” International Journal of Biological Macromolecules, vol. 57, pp. 259–264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. X.-D. Wu, W.-L. Liu, K. Zeng et al., “Advanced glycation end products activate the miRNA/RhoA/ROCK2 pathway in endothelial cells,” Microcirculation, vol. 21, no. 2, pp. 178–186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. L.-M. Li, D.-X. Hou, Y.-L. Guo et al., “Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes,” The Journal of Immunology, vol. 186, no. 4, pp. 2552–2560, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Lu, L. Jin Pu, Q. J. Chen et al., “Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients,” Clinica Chimica Acta, vol. 396, no. 1-2, pp. 33–37, 2008. View at Publisher · View at Google Scholar · View at Scopus